-
Je něco špatně v tomto záznamu ?
Effects of 2,3-Dehydrosilybin and Its Galloyl Ester and Methyl Ether Derivatives on Human Umbilical Vein Endothelial Cells
D. Karas, R. Gažák, K. Valentová, CS. Chambers, V. Pivodová, D. Biedermann, A. Křenková, I. Oborná, M. Kuzma, J. Cvačka, J. Ulrichová, V. Křen,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- endoteliální buňky pupečníkové žíly (lidské) účinky léků MeSH
- kyselina gallová farmakologie MeSH
- lidé MeSH
- methylethery farmakologie MeSH
- molekulární struktura MeSH
- scavengery volných radikálů chemie MeSH
- silymarin chemie farmakologie MeSH
- viabilita buněk účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The effects in vitro of 2,3-dehydrosilybin and several galloyl esters and methyl ethers on the viability, proliferation, and migration of human umbilical vein endothelial cells (HUVECs) were evaluated. The monogalloyl esters were synthesized by a chemoselective esterification method or by Steglich esterification of suitably protected 2,3-dehydrosilybin (1) with protected gallic acid. 2,3-Dehydrosilybin (1) displayed more potent cytotoxic, antiproliferative, and antimigratory activities (IC50 12.0, 5.4, and 12.2 μM, respectively) than silybin. The methylated derivatives were less active, with the least potent being 3,7-di-O-methyl-2,3-dehydrosilybin (6). On the other hand, galloylation at C-7 OH and C-23 OH markedly increased the cytotoxicity and the effects on the proliferation and migration of HUVECs. The most active derivative was 7-O-galloyl-2,3-dehydrosilybin (13; IC50 value of 3.4, 1.6, and 4.7 μM in the cytotoxicity, inhibition of proliferation, and antimigratory assays, respectively). Overall, this preliminary structure-activity relationship study demonstrated the importance of a 2,3-double bond, a C-7 OH group, and a galloyl moiety in enhancing the activity of flavonolignans toward HUVECs.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16027571
- 003
- CZ-PrNML
- 005
- 20161025105011.0
- 007
- ta
- 008
- 161005s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jnatprod.5b00905 $2 doi
- 024 7_
- $a 10.1021/acs.jnatprod.5b00905 $2 doi
- 035 __
- $a (PubMed)27015547
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Karas, Daniel
- 245 10
- $a Effects of 2,3-Dehydrosilybin and Its Galloyl Ester and Methyl Ether Derivatives on Human Umbilical Vein Endothelial Cells / $c D. Karas, R. Gažák, K. Valentová, CS. Chambers, V. Pivodová, D. Biedermann, A. Křenková, I. Oborná, M. Kuzma, J. Cvačka, J. Ulrichová, V. Křen,
- 520 9_
- $a The effects in vitro of 2,3-dehydrosilybin and several galloyl esters and methyl ethers on the viability, proliferation, and migration of human umbilical vein endothelial cells (HUVECs) were evaluated. The monogalloyl esters were synthesized by a chemoselective esterification method or by Steglich esterification of suitably protected 2,3-dehydrosilybin (1) with protected gallic acid. 2,3-Dehydrosilybin (1) displayed more potent cytotoxic, antiproliferative, and antimigratory activities (IC50 12.0, 5.4, and 12.2 μM, respectively) than silybin. The methylated derivatives were less active, with the least potent being 3,7-di-O-methyl-2,3-dehydrosilybin (6). On the other hand, galloylation at C-7 OH and C-23 OH markedly increased the cytotoxicity and the effects on the proliferation and migration of HUVECs. The most active derivative was 7-O-galloyl-2,3-dehydrosilybin (13; IC50 value of 3.4, 1.6, and 4.7 μM in the cytotoxicity, inhibition of proliferation, and antimigratory assays, respectively). Overall, this preliminary structure-activity relationship study demonstrated the importance of a 2,3-double bond, a C-7 OH group, and a galloyl moiety in enhancing the activity of flavonolignans toward HUVECs.
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a scavengery volných radikálů $x chemie $7 D016166
- 650 _2
- $a kyselina gallová $x farmakologie $7 D005707
- 650 _2
- $a endoteliální buňky pupečníkové žíly (lidské) $x účinky léků $7 D061307
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a methylethery $x farmakologie $7 D008738
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a silymarin $x chemie $x farmakologie $7 D012838
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Gažák, Radek $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic.
- 700 1_
- $a Valentová, Kateřina $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic.
- 700 1_
- $a Chambers, Christopher S $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic.
- 700 1_
- $a Pivodová, Veronika
- 700 1_
- $a Biedermann, David $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic.
- 700 1_
- $a Křenková, Alena $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic.
- 700 1_
- $a Oborná, Ivana $u Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, Palacký University and University Hospital , I.P. Pavlova 6, CZ-775 20 Olomouc, Czech Republic.
- 700 1_
- $a Kuzma, Marek $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic.
- 700 1_
- $a Cvačka, Josef $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences , Flemingovo nám. 2, CZ-16610 Prague 6, Czech Republic.
- 700 1_
- $a Ulrichová, Jitka
- 700 1_
- $a Křen, Vladimír $u Institute of Microbiology, Czech Academy of Sciences , Vídeňská 1083, CZ-142 20 Prague 4, Czech Republic.
- 773 0_
- $w MED00010055 $t Journal of natural products $x 1520-6025 $g Roč. 79, č. 4 (2016), s. 812-20
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27015547 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20161005 $b ABA008
- 991 __
- $a 20161025105425 $b ABA008
- 999 __
- $a ok $b bmc $g 1165885 $s 952201
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 79 $c 4 $d 812-20 $e 20160325 $i 1520-6025 $m Journal of natural products $n J Nat Prod $x MED00010055
- LZP __
- $a Pubmed-20161005